December 2019
Welcome to the December issue! From imagination to innovation: find out which innovative companies made made this year’s Innovation Awards in our cover feature. In Upfront, you can read about the EMA’s new home and how wood may be used to produce drugs; while Neil Cashman and James Kupiec give their thoughts on Biogen’s recently reanimated Alzhimer’s candidate. NextGen explores a three-in-one approach to drug delivery; and in Best Practice, Greg Thiele argues that contract laboratories need to be treated as equal partners rather than service providers. Last but not least, we Sit Down With Trevor Jones, Director of Arix Bioscience, e-Therapeutics and Respiratory Innovation Wales, UK.
The Innovators
December 30, 2019
Meet two companies helping to advance pharmaceutical development and manufacture.
1 min read
Manufacture
Facilities & Equipment
Technology & Manufacturing
Small Molecules
Bioprocessing
Biopharma
Cell & Gene
The Innovation Awards 2019
December 21, 2019
After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards. From single-use bioreactors, to formulation prediction tools, to Industry 4.0 technologies, we celebrate the solutions that help manufacturers make better medicines.
1 min read
The Best of the Best
December 18, 2019
Don’t forget to nominate pharma’s most talented individuals for the 2020 Power List!
1 min read
Hidden Analytical Advantages
December 12, 2019
Contract laboratories need to be treated as equal partners rather than service providers to optimize the benefits of outsourced pharmaceutical analysis
1 min read
In All FAIRness
December 11, 2019
After joining forces with Roche and Bayer, will the Pistoia Alliance’s latest toolkit help companies deal with the data explosion?
1 min read
Business & Regulation
Regulation & Standards
Business & Trends
Facilities & Equipment
Technology & Manufacturing
On to New Pastures
December 10, 2019
Dutch authorities hand over the keys to the EMA’s new HQ in the heart of Amsterdam’s financial district
1 min read
Joy to the World?
December 9, 2019
The UK’s “sovereignty” debate does not end with an agreed UK-EU relationship. It extends to all trading partners – with potential implications for pharma and patients across the world.
1 min read
Getting on Target for Alzheimer’s
December 5, 2019
Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity
1 min read
Why Small Molecules Are Still a Big Deal
December 5, 2019
Though large molecules and advanced therapies currently dominate headlines, small molecules remain of great significance for the industry – and patients
1 min read
Waste Not...
December 4, 2019
How can wood be used to produce pharmaceutically relevant compounds?
0 min read
Special Delivery
December 4, 2019
A novel protein-engineered hydrogel offers a less toxic sustained release alternative to synthetic platforms
0 min read
A Natural Combination
November 4, 2019
A three-in-one approach to drug delivery combines different actives in a hydrogel-based delivery method.
1 min read
